Inspra
utilized to support heart health and manage systemic pressure.
Strengths: 25 · 50mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Eptus
- Therapeutic class
Aldosterone Antagonist
- Pharmacological class
Potassium-sparing Diuretic
- Contraindications
hyperkalaemia; severe renal impairment; concurrent use of potassium supplements
- Minor side effects
dizziness; cough
- Moderate side effects
hyperkalaemia; hypotension
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
utilized to support heart health and manage systemic pressure.
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
2–4 weeks
- Duration
24 hours
- Storage instructions
Store at room temperature.
- Drug interactions
potassium supplements; ACE inhibitors
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: Use only if clearly needed. Breastfeeding: Not recommended.
Precautions and warnings
frequent serum potassium monitoring; monitor renal function; avoid grapefruit juice
Serious side effects
acute renal failure — requires immediate medical attention; severe hyperkalaemia — requires immediate medical attention
Mechanism of action
Eplerenone blocks aldosterone receptors, preventing sodium retention and hypertension, which helps reduce cardiovascular strain and improves outcomes in heart failure.
Inspra
utilized to support heart health and manage systemic pressure.
Editorial Notes
- Active ingredient(s): Eplerenone
- Listed indication(s): Heart Failure, Hypertension
Usually available as
- 60 tablets - 25 mg1049-25-mg-13204
- 30 tablets - 50 mg1049-50-mg-13208